SecProbe.io

CORRESP
1
filename1.htm

Charming
Medical Limited

Units 1803-1806, 18/F, Hang Lung Centre

2-20 Paterson Street, Causeway Bay, Hong Kong

September 29, 2025

VIA EDGAR

Division of Corporation Finance

Office of Industrial Applications and Services

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

Attn: Ms. Lauren Hamill and Mr. Chris Edwards

    Re:
    Charming Medical Limited

Registration Statement on Form F-1, as
amended (File No. 333-287258)

Request for Acceleration of Effectiveness

Ladies and Gentlemen:

In accordance with Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Charming Medical Limited hereby requests acceleration
of the effectiveness of the above-referenced Registration Statement on Form F-1, as amended, so that such Registration Statement
will become effective at 5:15 p.m., Eastern Time, on September 30, 2025, or as soon thereafter as practicable.

The Company understands that
the Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the
fact that the Company is aware of its responsibilities under the Securities Act as they relate to the proposed public offering of the
securities specified in the Registration Statement.

    Very truly yours,

    Charming Medical Limited

    By:
    /s/ Kit Wong

    Name:
    Kit Wong

    Title:
    Chief Executive Officer and Chairman of the Board